Correction to: Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

Tim A Labeur^{1

2}, R Bart Takkenberg³, Heinz-Josef Klümpen^{1

2}, Otto M van Delden⁴

Affiliations

¹ Cancer Center Amsterdam, Amsterdam, The Netherlands.
² Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
³ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
⁴ Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. o.m.vandelden@amc.nl.

Published Erratum

Tim A Labeur et al. Cardiovasc Intervent Radiol. 2019 Mar.

. 2019 Mar;42(3):484.

doi: 10.1007/s00270-018-2143-5.

Tim A Labeur^{1

2}, R Bart Takkenberg³, Heinz-Josef Klümpen^{1

2}, Otto M van Delden⁴

¹ Cancer Center Amsterdam, Amsterdam, The Netherlands.
² Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
³ Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
⁴ Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. o.m.vandelden@amc.nl.

Abstract

Toward the end of the second paragraph in the Discussion section, there is a word missing in the sentence.

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
Labeur TA, Takkenberg RB, Klümpen HJ, van Delden OM. Labeur TA, et al. Cardiovasc Intervent Radiol. 2019 Feb;42(2):230-238. doi: 10.1007/s00270-018-2118-6. Epub 2018 Nov 28. Cardiovasc Intervent Radiol. 2019. PMID: 30488302 Free PMC article.